关键词: 结核, 肺, 传染病控制, 成本及成本分析, 费用效益分析

Abstract: Objective To explore the social benefit generated by the funding for tuberculosis (TB) control and prevention from 2011 to 2019. Methods The data of smear positive TB patients treatment outcome and proportion of TB labor population from 2011 to 2019 were collected from theNational Tuberculosis Information Management System, and funds input of the government(including local and central government), international projects, and relevant data such as per capita GDP from 2011—2019 were collected as well. The most common methods in health economics such as cost-effectiveness, cost-utility, cost-benefit were applied to assess TB control social effect, social utility and social cost during 2011-2019. Results The total of 16.45 billion yuan of a variety of resources was invested during the year of 2011-2019, 2.473 million smear positive TB patients were treated successfully, 18.544 (11.127-27.816) million healthy people were protected from infection and 7.42 (4.45-11.13) billion yuan of medical expenses were saved, 714.57 billion yuan of social and economic losses were recovered. On the basis of current staff and facilities, every additional input of government with 1 yuan produced 43.9 (43.7-44.1) yuan economic benefits. It cost only 886.9 (591.3-1478.0) yuan for each healthy person to avoid infection. Only 933.5 yuan was needed to save the loss of a DALY. Conclusion From 2011 to 2019, the investment of governments and international projects in TB prevention and control has high health and economic benefits. It is suggested that governments at all levels continue to increase investment in TB prevention and control in order to achieve sustainable social benefits.

Key words: Tuberculosis, pulmonary, Communicable disease control, Costs and cost analysis, Cost-benefit analysis